Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome‐positive acute lymphoblastic leukaemia

Tyrosine kinase inhibitors (TKIs) have significantly improved the prognosis of Philadelphia chromosome‐positive acute lymphoblastic leukaemia (Ph(+) ALL), one of the most common and aggressive forms of haematological malignancies. However, TKI resistance has remained an unsolved issue. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Cheng, Chunyan, Peng, Lijun, Gao, Mengqing, Xi, Mengping, Rousseaux, Sophie, Khochbin, Saadi, Wang, Jin, Mi, Jianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824394/
https://www.ncbi.nlm.nih.gov/pubmed/29266867
http://dx.doi.org/10.1111/jcmm.13436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824394/
https://www.ncbi.nlm.nih.gov/pubmed/29266867
http://dx.doi.org/10.1111/jcmm.13436

Ejemplares similares